News
News from us and our partners
Tags
Topics
0 results
- News
DMC Secures $18M to Expand Health Ingredients Business
- News
CorWave completes enrollment in feasibility study and presents first clinical data on adaptive support with its Wave Membrane LVAD
- News
Muna Therapeutics announces positive Phase 1 results supporting potential of oral small-molecule TREM2 Modulator in Alzheimer’s disease
- News
TISSIUM® receives CE Mark for ECLIPSIUM®, Its atraumatic hernia repair solution
- News
F2G and Shionogi report data from Global Phase 3 OASIS Study evaluating investigational oral Olorofim versus AmBisome
- News
Bionyra Pharma Announces Positive Interim Phase 1 Results for BYN-002, a Long-Acting Anti-TL1A Antibody
- News
IMIO Raises $12M from Sofinnova Partners and Chipotle's Cultivate Next to Scale Reliable Biologicals and Improve Soil Performance
- News
Research from One Biosciences shows single-cell profiling can identify ovarian cancer tumors predisposed to chemotherapy resistance
- News
Sensorion announces the appointment of Peter Weber, MD, MBA, as Chief Medical Officer
- News
TIME names Recor Medical’s Paradise Ultrasound Renal Denervation System one of the Best Inventions of 2026
- News
COAPTIUM® CONNECT named one of TIME’s Best Inventions of 2026
- News
Mission Therapeutics doses first Parkinson’s patient in Phase 1b study of potential disease-modifying treatment MTX325
- News
Sitryx reports positive Phase 1b Results for oral PKM2 Modulator SYX-5219 in patients with moderate to severe atopic dermatitis
- News
GenSight Biologics and the 15-20 National Hospital announce NEJM publication on GS030 Phase 1/2 Trial results in late-stage retinitis pigmentosa
- News
Sensorion announces the appointment of Louis J. Arcudi III as Chief Financial Officer